Common Stock and Stock-Based Incentive Compensation Plans (Tables)
|
12 Months Ended |
Dec. 25, 2021 |
Share-based Payment Arrangement [Abstract] |
|
Schedule of Common Shares Outstanding |
Shares of common stock outstanding were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
December 25, 2021 |
|
December 26, 2020 |
|
December 28, 2019 |
|
(In millions) |
Balance, beginning of period |
1,211 |
|
|
1,170 |
|
|
1,005 |
|
Common stock issued under employee equity plans |
12 |
|
|
14 |
|
|
20 |
|
Repurchases of common stock |
(17) |
|
|
— |
|
|
— |
|
Common stock repurchases for tax withholding on equity awards |
(2) |
|
|
(1) |
|
|
— |
|
Issuance of common stock upon warrant exercise |
— |
|
|
— |
|
|
75 |
|
Issuance of common stock to settle convertible debt |
3 |
|
|
28 |
|
|
69 |
|
Issuance of treasury stock to partially settle debt |
— |
|
|
— |
|
|
1 |
|
Balance, end of period |
1,207 |
|
|
1,211 |
|
|
1,170 |
|
|
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs |
Stock-based compensation expense was allocated in the consolidated statements of operations as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 25, 2021 |
|
December 26, 2020 |
|
December 28, 2019 |
|
(In millions) |
Cost of sales |
$ |
5 |
|
|
$ |
6 |
|
|
$ |
6 |
|
Research and development |
246 |
|
|
173 |
|
|
129 |
|
Marketing, general, and administrative |
128 |
|
|
95 |
|
|
62 |
|
Total stock-based compensation expense before income taxes |
379 |
|
|
274 |
|
|
197 |
|
Income tax benefit |
(58) |
|
|
(42) |
|
|
— |
|
Total stock-based compensation expense, net of income taxes |
$ |
321 |
|
|
$ |
232 |
|
|
$ |
197 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions |
The weighted-average estimated fair value of employee stock options granted for the years ended December 25, 2021, December 26, 2020 and December 28, 2019 was $46.07, $38.49 and $13.31 per share, respectively, using the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 25, 2021 |
|
December 26, 2020 |
|
December 28, 2019 |
Expected volatility |
51.77 |
% |
|
57.87 |
% |
|
52.60% - 56.51% |
Risk-free interest rate |
0.69 |
% |
|
0.18 |
% |
|
1.53% - 2.51% |
Expected dividends |
— |
% |
|
— |
% |
|
— |
% |
Expected life (in years) |
4.55 |
|
4.30 |
|
3.94 - 3.95 |
The weighted-average grant date fair values of PRSUs granted during 2021, 2020 and 2019 were $153.89, $122.95 and $50.00, respectively, using the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 25, 2021 |
|
December 26, 2020 |
|
December 28, 2019 |
Expected volatility |
57.75 |
% |
|
55.74% - 60.10% |
|
60.54% - 62.52% |
Risk-free interest rate |
0.43 |
% |
|
0.14% - 1.41% |
|
1.56% - 2.49% |
Expected dividends |
— |
% |
|
— |
% |
|
— |
% |
Expected term (in years) |
3.00 |
|
2.48 - 3.00 |
|
2.48 - 5.00 |
|
Schedule of Share-based Compensation, Stock Options, Activity |
The following table summarizes stock option activity and related information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding Number of Shares |
|
Weighted- Average Exercise Price |
|
Aggregate Intrinsic Value |
|
Weighted-Average Remaining Contractual Life (in years) |
|
(In millions, except share price) |
|
|
Balance as of December 26, 2020 |
7 |
|
|
$ |
12.91 |
|
|
|
|
|
Granted |
1 |
|
|
$ |
107.58 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised |
(3) |
|
|
$ |
4.38 |
|
|
|
|
|
Balance as of December 25, 2021 |
5 |
|
|
$ |
23.98 |
|
|
$ |
614 |
|
|
2.80 |
Exercisable December 25, 2021 |
4 |
|
|
$ |
13.24 |
|
|
$ |
561 |
|
|
2.23 |
|
Schedule of Share-based Compensation, Restricted Stock Units, Activity |
The following table summarizes time-based RSU activity and related information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
Weighted- Average Grant-Date Fair Value |
|
Aggregate Intrinsic Value |
|
Weighted-Average Remaining Contractual Life (in years) |
|
(In millions except share price) |
|
|
Unvested shares as of December 26, 2020 |
12 |
|
|
$ |
43.98 |
|
|
|
|
|
Granted |
5 |
|
|
$ |
107.02 |
|
|
|
|
|
Forfeited |
(1) |
|
|
$ |
63.99 |
|
|
|
|
|
Vested |
(6) |
|
|
$ |
36.37 |
|
|
|
|
|
Unvested shares as of December 25, 2021 |
10 |
|
|
$ |
79.03 |
|
|
$ |
1,460 |
|
|
1.26 |
|
Schedule of Nonvested Performance-based Units Activity |
The following table summarizes PRSU activity and related information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
Weighted-Average Grant-Date Fair Value |
|
Aggregate Intrinsic Value |
|
Weighted-Average Remaining Contractual Life (in years) |
|
(In millions except share price) |
|
|
Unvested shares as of December 26, 2020 |
3 |
|
|
$ |
55.63 |
|
|
|
|
|
Granted |
— |
|
|
$ |
153.89 |
|
|
|
|
|
Forfeited |
— |
|
|
$ |
— |
|
|
|
|
|
Vested |
(1) |
|
|
$ |
24.40 |
|
|
|
|
|
Unvested shares as of December 25, 2021 |
2 |
|
|
$ |
78.59 |
|
|
$ |
338 |
|
|
1.50 |
|
Schedule of ESPP |
The weighted-average grant date fair value for the ESPP during 2021, 2020 and 2019 was $27.27, $20.97 and $9.96 per share, respectively, using the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 25, 2021 |
|
December 26, 2020 |
|
December 28, 2019 |
|
|
|
|
Expected volatility |
36.90% - 39.39% |
|
55.16% - 66.53% |
|
48.95% - 67.02% |
|
|
|
|
Risk-free interest rate |
0.04% - 0.07% |
|
0.11% - 0.15% |
|
1.58% - 2.46% |
|
|
|
|
Expected dividends |
— |
% |
|
— |
% |
|
— |
% |
|
|
|
|
Expected term (in years) |
0.50 |
|
0.50 |
|
0.50 |
|
|
|
|
|